oxa-48 carbapenemase in klebsiella pneumoniae sequence type 307 in ecuador

Clicks: 166
ID: 135286
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Antibiotic resistance is on the rise, leading to an increase in morbidity and mortality due to infectious diseases. Klebsiella pneumoniae is a Gram-negative bacterium that causes bronchopneumonia, abscesses, urinary tract infection, osteomyelitis, and a wide variety of infections. The ubiquity of this microorganism confounds with the great increase in antibiotic resistance and have bred great concern worldwide. K. pneumoniae sequence type (ST) 307 is a widespread emerging clone associated with hospital-acquired infections, although sporadic community infections have also been reported. The aim of our study is to describe the first case of Klebsiella pneumoniae (ST) 307 harboring the blaOXA-48-like gene in Ecuador. We characterized a new plasmid that carry OXA-48 and could be the source of future outbreaks. The strain was recovered from a patient with cancer previously admitted in a Ukrainian hospital, suggesting that this mechanism of resistance could be imported. These findings highlight the importance of programs based on active molecular surveillance for the intercontinental spread of multidrug-resistant microorganisms with emergent carbapenemases.
Reference Key
villacs2020microorganismsoxa-48 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;José E. Villacís;Jorge A. Reyes;Hugo G. Castelán-Sánchez;Sonia Dávila-Ramos;Miguel Angel Lazo;Ahmad Wali;Luis A. Bodero;Yadira Toapanta;Cristina Naranjo;Lorena Montero;Josefina Campos;Marcelo G. Galas;Mónica C. Gestal
Journal advances in astronomy
Year 2020
DOI
10.3390/microorganisms8030435
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.